Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 14/20 | 1.00 |
| ▸ | PTPN2 | P17706 | 5/20 | 1.00 |
| ▸ | PTPN6 | P29350 | 5/20 | 1.00 |
| ▸ | PTPN11 | Q06124 | 4/20 | 1.00 |
| ▸ | PGK1 | P00558 | 3/20 | 0.69 |
| ▸ | PGK2 | P07205 | 3/20 | 0.69 |
| ▸ | PTPRB | P23467 | 3/20 | 0.60 |
| ▸ | PTPRC | P08575 | 2/20 | 0.60 |
| ▸ | CDC25A | P30304 | 1/20 | 0.60 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19696718 | 0.90 | PTPN1 (0.81) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL6664712 | 0.89 | PTPN1 (0.79) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL20672233 | 0.88 | PTPN1 (0.78) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL4316972 | 0.86 | PTPN1 (0.74) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL330067 | 0.82 | PTPN1 (0.70) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL19696719 | 0.82 | PTPN1 (0.70) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL7535721 | 0.81 | PGK1 (0.69) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL19696720 | 0.81 | PTPN1 (0.66) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL19996618 | 0.80 | PTPN1 (0.66) | PTPN1PTPN2PTPN6PTPN11PGK1 | |
| SCHEMBL7166929 | 0.80 | PTPN1 (0.64) | PTPN1PTPN2PTPN6PTPN11PGK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |